{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1223.10","meta":{"versionId":"5","lastUpdated":"2020-04-07T01:00:20.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1223.10","version":"20200407","name":"COVID19 Encounters (CPT4)","status":"active","date":"2020-04-07T01:00:20-04:00","publisher":"CareEvolution Steward","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","version":"2021","concept":[{"code":"87635","display":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique"}]}]},"expansion":{"identifier":"urn:uuid:3a76dec2-fd5d-4f6b-a9fc-4373b5a1b104","timestamp":"2022-06-10T06:15:28-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"87635","display":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique"}]}}